Effects of Pulmonary Rehabilitation in Patients With Restrictive Lung Diseases


      Pulmonary rehabilitation programs improve exercise tolerance, muscle strength, and dyspnea in patients with COPD. The aim of the study was to assess prospectively the effectiveness and feasibility of pulmonary rehabilitation in patients with restrictive lung diseases.


      In a prospective, nonrandomized, noncontrolled study, patients with an established diagnosis of restrictive lung disease (RLD) participated in a 24-week outpatient multidisciplinary rehabilitation program. Pulmonary function, exercise capacity, muscle force, and dyspnea were measured at inclusion, after 12 and 24 weeks of rehabilitation. Primary outcome was the change in 6-min walk distance (6MWD) after 12 weeks of rehabilitation.


      Twenty-nine patients out of 31 patients (57 ± 17 years of age; 21 men; FEV1: 1.4 ± 0.7 L) completed the 12-week rehabilitation program and 26 patients the 24-week rehabilitation program. At inclusion, exercise tolerance (maximal oxygen consumption [Vo2max]: 63% ± 27% predicted; 6MWD: 390 ± 140 m) and quadriceps force ([QF] 61% ± 21% predicted) were reduced, and dyspnea, assessed using the Chronic Respiratory Disease Questionnaire (CRDQ), was increased (CRDQ item dyspnea [CRDQd]: 16 ± 6 points). Exercise capacity, muscle force, and CRDQd improved significantly after 12 weeks (6MWD: 445 ± 142 m; VO2max: 69% ± 30% predicted; QF: 73% ± 25% predicted; CRDQd: 20 ± 6 points) (P < .05). Further improvements were noted after 24 weeks (6MWD: 463 ± 146 m; CRDQd: 22 ± 6 points).


      Patients with RLD respond well after 12 weeks of pulmonary rehabilitation, and even better results were seen after 24 weeks. Clinically significant improvements were obtained in the majority of the patients after 24 weeks.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Novitch RS
        • Thomas HM
        Rehabilitation of patients with chronic ventilatory limitation from non obstructive lung diseases.
        in: Casaburi R Petty TL Principles and Practice of Pulmonary Rehabilitation. Saunders, Philadelphia, PA1992: 416-423
        • Hsia CC
        Cardiopulmonary limitations to exercise in restrictive lung disease.
        Med Sci Sports Exerc. 1999; 31: S28-S32
        • Naji NA
        • Connor MC
        • Donnelly SC
        • McDonnell TJ
        Effectiveness of pulmonary rehabilitation in restrictive lung disease.
        J Cardiopulm Rehabil. 2006; 26: 237-243
        • Herridge MS
        • Cheung AM
        • Tansey CM
        • Canadian Critical Care Trials Group
        • et al.
        One-year outcomes in survivors of the acute respiratory distress syndrome.
        N Engl J Med. 2003; 348: 683-693
        • Troosters T
        • Casaburi R
        • Gosselink R
        • Decramer M
        Pulmonary rehabilitation in chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2005; 172: 19-38
        • Ries AL
        • Bauldoff GS
        • Carlin BW
        • et al.
        Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines.
        Chest. 2007; 131: 4S-42S
        • Nici L
        • Donner C
        • Wouters E
        • ATS/ERS Pulmonary Rehabilitation Writing Committee
        • et al.
        American Thoracic Society/European Respiratory Society statement on pulmonary ehabilitation.
        Am J Respir Crit Care Med. 2006; 173: 1390-1413
        • Singh SJ
        • Smith DL
        • Hyland ME
        • Morgan MD
        A short outpatient pulmonary rehabilitation programme: immediate and longer-term effects on exercise performance and quality of life.
        Respir Med. 1998; 92: 1146-1154
        • Foster S
        • Thomas HM
        Pulmonary rehabilitation in lung diseases other than chronic obstructive pulmonary disease.
        Am Rev Respir Dis. 1990; 141: 601-604
        • Ferreira G
        • Feuerman M
        • Spiegler P
        Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease.
        J Cardiopulm Rehabil. 2006; 26: 54-60
        • Nishiyama O
        • Kondoh Y
        • Kimura T
        • et al.
        Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.
        Respirology. 2008; 13: 394-399
        • Holland AE
        • Hill CJ
        • Conron M
        • Munro P
        • McDonald CF
        Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease.
        Thorax. 2008; 63: 549-554
        • Holland A
        • Hill C
        Physical training for interstitial lung disease.
        Cochrane Database Syst Rev. 2008; (CD006322)
        • Troosters T
        • Gosselink R
        • Derom E
        • et al.
        Efficacy of pulmonary rehabilitation in a clinical setting [abstract].
        Am J Respir Crit Care Med. 2002; 165: 735
        • Quanjer PH
        • Tammeling GJ
        • Cotes JE
        • Pedersen OF
        • Peslin R
        • Yernault JC
        Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.
        Eur Respir J Suppl. 1993; 16: 5-40
        • Troosters T
        • Gosselink R
        • Decramer M
        Six minute walking distance in healthy elderly subjects.
        Eur Respir J. 1999; 14: 270-274
        • Decramer M
        • Lacquet LM
        • Fagard R
        • Rogiers P
        Corticosteroids contribute to muscle weakness in chronic airflow obstruction.
        Am J Respir Crit Care Med. 1994; 150: 11-16
        • Rochester DF
        • Arora NS
        Respiratory muscle failure.
        Med Clin North Am. 1983; 67: 573-597
        • Miller MR
        • Hankinson J
        • Brusasco V
        • et al.
        Standardisation of spirometry.
        Rev Mal Respir. 2007; 24: 2527-2549
        • Ross RM
        ATS/ACCP statement on cardiopulmonary exercise testing.
        Am J Respir Crit Care Med. 2003; 167: 1451
        • Troosters T
        • Gosselink R
        • Decramer M
        Exercise training in COPD: how to distinguish responders from nonresponders.
        J Cardiopulm Rehabil. 2001; 21: 10-17
        • Black LF
        • Hyatt RE
        Maximal respiratory pressures: normal values and relationship to age and sex.
        Am Rev Respir Dis. 1969; 99: 696-702
        • Guyatt GH
        • Berman LB
        • Townsend M
        • Pugsley SO
        • Chambers LW
        A measure of quality of life for clinical trials in chronic lung disease.
        Thorax. 1987; 42: 773-778
        • Gosselink HA
        • Wagenaar RC
        • Keimpema VA
        The effects of a rehabilitation program in patients with COPD.
        Ned tijdschr Fysioth. 1990; 100: 193-199
        • Troosters T
        • Gosselink R
        • Decramer M
        Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.
        Am J Med. 2000; 109: 207-212
        • Jones NL
        • Makrides L
        • Hitchcock C
        • Chypchar T
        • McCartney N
        Normal standards for an incremental progressive cycle ergometer test.
        Am Rev Respir Dis. 1985; 131: 700-708
        • Redelmeier DA
        • Bayoumi AM
        • Goldstein RS
        • Guyatt GH
        Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients.
        Am J Respir Crit Care Med. 1997; 155: 1278-1282
        • Ries AL
        • Make BJ
        • Lee SM
        • National Emphysema Treatment Trial Research Group
        • et al.
        The effects of pulmonary rehabilitation in the national emphysema treatment trial.
        Chest. 2005; 128: 3799-3809
        • Ferreira A
        • Garvey C
        • Connors GL
        • et al.
        Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response.
        Chest. 2009; 135: 442-447
        • Lacasse Y
        • Martin S
        • Lasserson TJ
        • Goldstein RS
        Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review.
        Eura Medicophys. 2007; 43: 475-485
        • Nishiyama O
        • Taniguchi H
        • Kondoh Y
        • et al.
        Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis.
        Chest. 2005; 127: 2028-2033
        • Ando M
        • Mori A
        • Esaki H
        • et al.
        The effect of pulmonary rehabilitation in patients with post-tuberculosis lung disorder.
        Chest. 2003; 123: 1988-1995

      Linked Article

      • Pulmonary Rehabilitation for Restrictive Lung Diseases
        CHESTVol. 137Issue 2
        • Preview
          Chronic respiratory conditions share a number of common manifestations, such as dyspnea, cough, fatigue, and inactivity. In addition, patients often experience secondary peripheral muscle, cardiac, nutritional, and psychologic impairments, which individually or in combination with their respiratory condition further limit exercise capacity and health-related quality of life (HRQL). The resulting impact on personal and family life, as well as the associated increase in health-care use, is well known.
        • Full-Text
        • PDF